Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
A novel imaging technique could enable biopsy-free breast screening
Breast cancer is the most common form of cancer in women and accounts for 28…
A smart bra for detecting early-stage breast cancer
Swiss students from Ecole Polytechnique Federale de Lausanne teamed up with startup IcosaMed to develop…
COVID-19 takes its toll on kids with cancer
As the coronavirus pandemic triggers greater isolation measures, thousands of children with cancer and their…
Australian men with breast cancer need different care
COSA ASM: Australian men with breast cancer require more specialised care, treatment and support, according to cancer expert who presented…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.